Marco V Haselager

3PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.

Simon Mobach, Nick D Bergkamp, Ziliang Ma

|Dec 23, 2022
JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.

Marco V Haselager, Rachel Thijssen, Danique Bax

Pageof 1